More than 30,000 Australians who are at high risk of contracting HIV may soon be able to access a taxpayer-subsidised preventative drug, should a Federal government health body approve its listing on the Pharmaceutical Benefits Scheme (PBS). Different studies have found PrEP could have an effectiveness rate of stopping HIV infections upwards of 90 per cent. "You would be aware that for HIV negative people who are at high risk of HIV, PrEP has been proven to be highly effective in preventing HIV transmission," he wrote at the time. "Australia is also lagging behind in terms of other prevention tools like rapid HIV tests and home testing. The government should be doing all it can to make these available so that Australians have access to the broadest, most effective range of HIV prevention tools."

Source: Huffington Post August 07, 2017 09:56 UTC